Works about BREAST cancer patients


Results: 5000
    1
    3
    4
    5
    6
    7

    Breast.

    Published in:
    2006
    Publication type:
    Book Chapter
    8
    9
    10
    11

    Neon.

    Published in:
    Gulf Coast: A Journal of Literature & Fine Arts, 2015, v. 27, n. 2, p. 208
    By:
    • May-lee Chai
    Publication type:
    Article
    12
    13
    14

    ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor Cells.

    Published in:
    PLoS Biology, 2015, v. 13, n. 12, p. 1, doi. 10.1371/journal.pbio.1002330
    By:
    • Gallego-Ortega, David;
    • Ledger, Anita;
    • Roden, Daniel L.;
    • Law, Andrew M. K.;
    • Magenau, Astrid;
    • Kikhtyak, Zoya;
    • Cho, Christina;
    • Allerdice, Stephanie L.;
    • Lee, Heather J.;
    • Valdes-Mora, Fatima;
    • Herrmann, David;
    • Salomon, Robert;
    • Young, Adelaide I. J.;
    • Lee, Brian Y.;
    • Sergio, C. Marcelo;
    • Kaplan, Warren;
    • Piggin, Catherine;
    • Conway, James R. W.;
    • Rabinovich, Brian;
    • Millar, Ewan K. A.
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    22
    23
    24
    25
    26
    27
    28

    Systemic NF-κB activation in blood cells of breast cancer patients.

    Published in:
    Redox Report, 2006, v. 11, n. 1, p. 39, doi. 10.1179/135100006X101002
    By:
    • Adz̆ić, Miroslav;
    • Nićiforović, Ana;
    • Vuc̆ić, Vesna;
    • Nes̆ković-Konstantinović, Zora;
    • Spasić, Snez̆ana D.;
    • Jones, David R.;
    • Radojc̆ić, Marija B.;
    • Spasić, Mihajlo B.
    Publication type:
    Article
    29

    Clinical Clips.

    Published in:
    Patient Care (Print), 2000, v. 34, n. 18, p. 78
    By:
    • LoBuono, Charlotte
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 361, doi. 10.1007/s00280-008-0882-8
    By:
    • Ishida, Takanori;
    • Kiba, Takayoshi;
    • Takeda, Motohiro;
    • Matsuyama, Kotone;
    • Teramukai, Satoshi;
    • Ishiwata, Ryota;
    • Masuda, Norikazu;
    • Takatsuka, Yuichi;
    • Noguchi, Shinzaburo;
    • Ishioka, Chikashi;
    • Fukushima, Masanori;
    • Ohuchi, Noriaki
    Publication type:
    Article
    50